Robert James Wills, Director at Oncternal Therapeutics, Inc. (ONCT), sold 980 shares at $9.04 ($9K) on 2024-02-23, disclosed to the SEC on 2024-02-27.
Open-market sale of $9k ONCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ONCT | BUY | 2024-04-10 | $28K | — | Filing → |
| ONCT | BUY | 2024-04-01 | $117K | — | Filing → |
| MIST | BUY | 2022-10-21 | $74K | — | Filing → |